Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

POU2F3 in SCLC: Clinicopathologic and Genomic Analysis With a Focus on Its Diagnostic Utility in Neuroendocrine-Low SCLC
Marina K. Baine, Christopher A. Febres‐Aldana, Jason C. Chang, et al.
Journal of Thoracic Oncology (2022) Vol. 17, Iss. 9, pp. 1109-1121
Open Access | Times Cited: 52

Showing 1-25 of 52 citing articles:

Clinical insights into small cell lung cancer: Tumor heterogeneity, diagnosis, therapy, and future directions
Zsolt Megyesfalvi, Carl M. Gay, Helmut Popper, et al.
CA A Cancer Journal for Clinicians (2023) Vol. 73, Iss. 6, pp. 620-652
Open Access | Times Cited: 169
KDM6A epigenetically regulates subtype plasticity in small cell lung cancer
Leslie Duplaquet, Yixiang Li, Matthew A. Booker, et al.
Nature Cell Biology (2023) Vol. 25, Iss. 9, pp. 1346-1358
Closed Access | Times Cited: 36
Genetically-engineered mouse models of small cell lung cancer: the next generation
Matthew G. Oser, David MacPherson, Trudy G. Oliver, et al.
Oncogene (2024)
Open Access | Times Cited: 13
Molecular phenotyping of small cell lung cancer using targeted cfDNA profiling of transcriptional regulatory regions
Joseph B. Hiatt, Anna-Lisa Doebley, Henry U. Arnold, et al.
Science Advances (2024) Vol. 10, Iss. 15
Open Access | Times Cited: 10
Mammalian SWI/SNF complex activity regulates POU2F3 and constitutes a targetable dependency in small cell lung cancer
Leslie Duplaquet, Kevin Kam Fung So, Alexander W. Ying, et al.
Cancer Cell (2024) Vol. 42, Iss. 8, pp. 1352-1369.e13
Open Access | Times Cited: 10
Small cell lung cancer profiling: an updated synthesis of subtypes, vulnerabilities, and plasticity
Esther Redín, Álvaro Quintanal-Villalonga, Charles M. Rudin
Trends in cancer (2024) Vol. 10, Iss. 10, pp. 935-946
Closed Access | Times Cited: 8
Integrative spatial analysis reveals tumor heterogeneity and immune colony niche related to clinical outcomes in small cell lung cancer
Haiquan Chen, Chaoqiang Deng, Jian Gao, et al.
Cancer Cell (2025)
Closed Access | Times Cited: 1
Current and future therapies for small cell lung carcinoma
Xiaoqian Zhai, Zhengkun Zhang, Yuxin Chen, et al.
Journal of Hematology & Oncology (2025) Vol. 18, Iss. 1
Open Access | Times Cited: 1
Neuroendocrine neoplasms of the lung and gastrointestinal system: convergent biology and a path to better therapies
Kenta Kawasaki, Natasha Rekhtman, Álvaro Quintanal-Villalonga, et al.
Nature Reviews Clinical Oncology (2022) Vol. 20, Iss. 1, pp. 16-32
Closed Access | Times Cited: 31
Emerging Biomarkers and the Changing Landscape of Small Cell Lung Cancer
Anna Keogh, Stephen P. Finn, Teodora Radonic
Cancers (2022) Vol. 14, Iss. 15, pp. 3772-3772
Open Access | Times Cited: 28
Olfactory neuroblastoma mimics molecular heterogeneity and lineage trajectories of small-cell lung cancer
John B. Finlay, Abbie S. Ireland, Sarah B. Hawgood, et al.
Cancer Cell (2024) Vol. 42, Iss. 6, pp. 1086-1105.e13
Open Access | Times Cited: 6
Chemosensory cells in the respiratory tract as crucial regulators of innate immune responses
Monika I. Hollenhorst, Gabriela Krasteva‐Christ
The Journal of Physiology (2023) Vol. 601, Iss. 9, pp. 1555-1572
Open Access | Times Cited: 15
Updates on lung neuroendocrine neoplasm classification
Giulia Trucco, Luisella Righi, Marco Volante, et al.
Histopathology (2023) Vol. 84, Iss. 1, pp. 67-85
Open Access | Times Cited: 14
Spatially Preserved Multi-Region Transcriptomic Subtyping and Biomarkers of Chemoimmunotherapy Outcome in Extensive-Stage Small Cell Lung Cancer
Melina Peressini, Rosario García-Campelo, Bartomeu Massutí, et al.
Clinical Cancer Research (2024) Vol. 30, Iss. 14, pp. 3036-3049
Closed Access | Times Cited: 5
Clinical utility of immunohistochemical subtyping in patients with small cell lung cancer
Chi‐Lu Chiang, Hsu-Ching Huang, Yung‐Hung Luo, et al.
Lung Cancer (2024) Vol. 188, pp. 107473-107473
Closed Access | Times Cited: 4
Updates on Urinary Bladder Tumors With Neuroendocrine Features
Dilara Akbulut, Hikmat Al‐Ahmadie
Advances in Anatomic Pathology (2024) Vol. 31, Iss. 3, pp. 169-177
Closed Access | Times Cited: 4
Brief Report: CD5 Immunoreactivity is Associated with Longer Overall Survival in Thymic Carcinoma
Julia Naso, Sarah M. Jenkins, Julie A. Vrana, et al.
JTO Clinical and Research Reports (2025) Vol. 6, Iss. 5, pp. 100803-100803
Open Access
Noninvasive molecular imaging using anti-Trop-2 aptamer for targeted therapy of small cell lung cancer
Yamei Chen, Xuwei Liu, Yang Sun, et al.
Journal of Nanobiotechnology (2025) Vol. 23, Iss. 1
Open Access
Clinical Impact of POU2F3 Expression in Surgically Resected Pulmonary High-Grade Neuroendocrine Carcinoma
Suguru Mitsui, Naoe Jimbo, Yugo Tanaka, et al.
Cureus (2025)
Open Access
Clinicopathological characteristics of transcription factor-defined subtypes in bladder small cell carcinoma
Keiichiro Kitahama, Yasuyuki Shigematsu, Emiko Sugawara, et al.
BMC Cancer (2025) Vol. 25, Iss. 1
Open Access
Extracellular Vesicular Delta‐Like Ligand 3 and Subtype Transcription Factors for Small Cell Lung Cancer Diagnosis
Hong Li, Chi‐Ling Chiang, Kwang Joo Kwak, et al.
Advanced Science (2025)
Open Access
Overview of the histopathological and immunohistochemical characteristics of neuroendocrine neoplasms
Sonia L. El-Sharkawy, Manal Badawi, Wafaa E. Abdelaal, et al.
Bulletin of the National Research Centre/Bulletin of the National Research Center (2025) Vol. 49, Iss. 1
Open Access
In‐depth proteomic analysis reveals unique subtype‐specific signatures in human small‐cell lung cancer
Beáta Szeitz, Zsolt Megyesfalvi, Nicole Woldmar, et al.
Clinical and Translational Medicine (2022) Vol. 12, Iss. 9
Open Access | Times Cited: 18
Subtype of SCLC Is an Intrinsic and Persistent Feature Through Systemic Treatment
Ying‐Chun Lo, Joel Rivera‐Concepción, George Vasmatzis, et al.
JTO Clinical and Research Reports (2023) Vol. 4, Iss. 9, pp. 100561-100561
Open Access | Times Cited: 9
Heterogeneity of molecular subtyping and therapy-related marker expression in primary tumors and paired lymph node metastases of small cell lung cancer
Yanli Zhu, Wenhao Ren, Sheng Li, et al.
Virchows Archiv (2024)
Closed Access | Times Cited: 3
Page 1 - Next Page

Scroll to top